Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -181.21x is 396% below its 2-year average of -36.50x, near the low end of its 2-year range (-181.21x–-0.29x).
As of the fiscal period ended Friday, September 30, 2011. 133.68% below its 12-month average of -77.55x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2011 (2011-09-30): -181.21x.
INTEREST COVERAGE RATIO
-181.21x
INTEREST COVERAGE RATIO AVG TTM
-77.55x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-133.68%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-2.21x
median of 261 covered companies
CURRENT VS SECTOR MEDIAN
-8099.50%
vs the sector median at left
Assembly Biosciences, Inc.
Market Cap
$450.64M
Interest Coverage Ratio
-181.21x
TTM Avg
-77.55x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$453.70M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$447.43M
Interest Coverage Ratio
-35.51x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$468.31M
Interest Coverage Ratio
4.74x
TTM Avg
9.15x
3Y Avg
25.82x
5Y Avg
26.16x
Market Cap
$471.57M
Interest Coverage Ratio
-1.04x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$428.16M
Interest Coverage Ratio
-16.10x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$478.54M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$416.68M
Interest Coverage Ratio
N/A
TTM Avg
4.06x
3Y Avg
4.06x
5Y Avg
4.06x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Assembly Biosciences, Inc. (ASMB) | $450.64M | -181.21x | -77.55x | N/A | N/A |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $453.70M | N/A | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $447.43M | -35.51x | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $468.31M | 4.74x | 9.15x | 25.82x | 26.16x |
| Cerus Corporation (CERS)vs › | $471.57M | -1.04x | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $428.16M | -16.10x | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $481.33M | N/A | N/A | N/A | N/A |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $416.68M | N/A | 4.06x | 4.06x | 4.06x |
| Carlsmed, Inc. (CARL)vs › | $415.93M | -21.38x | N/A | N/A | N/A |
Interest Coverage
-181.2x
Debt/Equity
0.01
Current Ratio
13.99
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2011-09-30 | -181.21x |
| 2011-06-30 | -166.72x |
| 2011-03-31 | -38.55x |
| 2010-12-31 | -0.51x |
| 2010-09-30 | -0.74x |
| 2010-06-30 | -0.96x |
| 2010-03-31 | -0.29x |
| 2009-12-31 | -1.88x |
| 2009-09-30 | -3.21x |
| 2009-06-30 | -1.94x |
| 2009-03-31 | -5.51x |
